DIDB® Concomitant Meds Navigator
Explore the Concomitant Meds Navigator withing DIDB - An evidence-based tool within DIDB that helps…
CertaraApril 27, 2026
3 Things You Should Know About ADaM Standards
Learn the key aspects of ADaM standards, including the difference between SDTM and ADaM and…
CertaraApril 27, 2026
Certara Enables Discovery Scientists to Accelerate Therapeutic Peptide Discovery with New D360 version
Discover how D360 26.0 enhances peptide design, sequence analysis, and workflows to help scientists accelerate…
CertaraApril 23, 2026
Top 10 Benefits of Simcyp® Simulator for Drug Development
JTVCdGVhbV9qdW1wX2xpc3QlNUQ= April 23, 2026 Physiologically based pharmacokinetic (PBPK) modeling has evolved from an emerging methodology…
CertaraApril 23, 2026
ADC Dose Optimization: Applying Model-Informed Strategies in Development
Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…
CertaraApril 22, 2026
Certara Talks – Pivotal Trial Mandate
Explore how the FDA’s shift toward one pivotal trial plus supporting evidence could reshape drug…
CertaraApril 22, 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat
Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to…
CertaraApril 22, 2026
BaseCase® Turn Evidence into Decisions – at Scale
BaseCase value communication software transforms complex economic models and clinical data into interactive, field-ready tools.
Danielle PillsburyApril 21, 2026
FDA ESG Integration: Why Now Is the Time to Move Beyond Manual Submissions
Discover how FDA Electronic Submissions Gateway (ESG) integration reduces manual work, improves compliance, and accelerates…
CertaraApril 20, 2026
Modeling Hope: From Patient to Scientist Ellen Swanson on QSP, Breast Cancer, and Hope Through Science
Ellen Swanson, QSP Senior Scientist at Certara, shares her personal journey from breast cancer diagnosis…
CertaraApril 16, 2026
